OFFER DESCRIPTION
SHORT DEADLINE: 3rd March 2021
InPharma is a MSCA European Industrial Doctorate programme offering a
comprehensive training program addressing the challenges of developing
emerging drug candidates into new licensed medicines, including
innovative modeling and bio-predictive tools tailored to streamline the
oral drug product development process.
InPharma brings together global pharmaceutical companies and leading
research institutions together as a multi-sectorial team to deliver a
unique research and training programme for 13 Early Stage Researchers
(ESR) to complete their industrially based PhDs.
Each ESR position in InPharma allows the researcher to work towards a
PhD at one of our five leading academic institutions. The ESRs will be
recruited within 2021 for a duration of 36 months. Every ESR will work
on an independent research project which will be flexible enough to
match the competence and goals of the candidate.
Marie Sklodowska-Curie ESRs are paid an attractive gross salary of
3,270 €/month for 36 months (as defined in MSCA guidelines). The exact
(net) salary will be confirmed upon appointment and is dependent on
local tax, social and health insurance regulations and on the country
correction factor (to allow for the difference in cost of living in the
different EU Member States). Each ESR will also be compensated with a
Mobility Allowance of 600 €/month, and, for researchers who have
afamily, a Family Allowance of 500 €/month. All amounts are subject to
deductions and taxes. Family is defined as persons linked to the
researcher by (i) marriage, or (ii) a relationship with equivalent
status to a marriage recognised by the national legislation of the
country of the beneficiary or of the nationality of the researcher, or
(iii) dependent children who are actually being maintained by the
researcher; family status is determined at recruitment and does not
evolve.
Position include interdisciplinary training, summer schools and yearly international meetings.
Available Position:
ESR9: Development of an in vitro method for evaluating the
impact of gastrointestinal (GI) transfer on performance of enabling
formulations under fed state conditions
Host: National and Kapodistrian University of Athens (NKUA, Greece)
PhD awarding institution: NKUA
Objectives:
Scientific: 1) Conduct a clinical study to assess
the GI transfer process of amorphous solid dispersions in the fed state;
2) Design biorelevant in vitro testing conditions for evaluating the
drug disposition in the upper GI lumen after oral administration of
immediate release/enabling products in the fed state.
Industrial: Develop and assess the utility of in
vitro models to reproduce intraluminal drug data, after administration
of immediate release/enabling products in the fed state.
Planned secondment:Host: Janssen, Belgium; Duration: ~18 months
Skills/Qualifications
The applicant must:
- Have a Master’s degree (or any equivalent diploma) in relevant
area (e.g. PPharmacy, Pharmaceutical Sciences, Drug Delivery or
Industrial Pharmacy).
- Should be — at the date of recruitment — an ‘early stage
researcher (ESR)’, i.e. in the first 4 years (full-time equivalent) of
his/her research career and must not have a PhD doctoral degree. This is
measured from the date when they obtained the degree which would
formally entitle them to embark on a doctorate, either in the country
which the degree was obtained or in the country in which the research
training is provided.
- Satisfy MSCA rules for Trans-national mobility: The applicant
should not have resided in the country where the research training
activities take place for more than 12 months in the 3 years immediately
prior to the recruitment date and not have carried out their main
activity (work, studies, etc.) in that country.
- Have solid written and oral communication skills in English as
communication and teaching language throughout InPharma is English.
Candidates who are not fluent in English are requested to provide proof
of English proficiency (in speaking and writing) (e.g. (typically IELTS
min. 7, TOEFL internet-based min. 90 or similar level as proven by other
tests).